After implementing automated compliance checks in Windchill 12.0 for our medical device manufacturing, I’m reflecting on the balance between automation and manual oversight. We’ve automated basic regulatory checks for FDA 21 CFR Part 820 compliance, but certain risk-based assessments still require human judgment.
Our automated workflow routes documents based on risk classification, but the audit trail requirements have become complex. Some industry-specific compliance rules are straightforward to automate (material restrictions, labeling requirements), while others involving clinical data interpretation need expert review.
I’m curious how others approach this balance. When do you keep manual compliance checks versus automating them? How do you handle risk-based workflow routing while maintaining comprehensive audit trails for regulatory submissions?
That hybrid confidence-scoring approach is interesting. How do you validate the automated rules themselves? Our auditors want evidence that the automation logic correctly implements regulatory requirements.
From a technical perspective, I recommend separating compliance rule configuration from application code. We externalized rules into XML configuration files that compliance team can review directly. Each rule version is tracked in Windchill itself as a controlled document. When rules change due to regulatory updates, we follow our standard change management process including impact assessment and validation testing.
We maintain a validation matrix mapping each automated rule to specific regulatory clauses. During implementation, we run parallel testing - automated system alongside manual reviews for 90 days. Document discrepancies, tune the rules, then formally validate. The validation package includes test cases, traceability matrices, and approval signatures. Auditors have accepted this approach across three FDA inspections.
The audit trail complexity you mention resonates with our pharmaceutical experience. We implemented a hybrid model where automation handles first-pass compliance screening and generates detailed audit logs. The system flags edge cases for manual review. Key was defining clear escalation criteria - when automated confidence scores fall below thresholds, it triggers manual workflow. This maintains regulatory defensibility while gaining efficiency. For 21 CFR Part 11, we ensure all automated decisions are traceable with electronic signatures on the validation rules themselves.